Selective inhibitors of apoptotic caspases: implications for novel therapeutic strategies

被引:34
作者
Nuttall, ME
Lee, D
McLaughlin, B
Erhardt, JA
机构
[1] SmithKline Beecham Pharmaceut, Dept Cardiovasc Pharmacol, King Of Prussia, PA 19406 USA
[2] SmithKline Beecham Pharmaceut, Dept Med Chem, Redwood City, CA 94063 USA
[3] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15261 USA
关键词
D O I
10.1016/S1359-6446(00)01601-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Caspases are essential for apoptosis. A crucial question regarding the role(s) of these proteases is whether the selective inhibition of an effector caspase will prevent cell death. We have identified potent, selective non-peptide inhibitors of the effector caspases 3 and 7. Apoptosis can be inhibited and cell functionality maintained using an inhibitor selective for caspases 3 and 7. This has important therapeutic implications and the potential to generate novel anti-apoptotic strategies in diseases that involve dysregulated apoptosis.
引用
收藏
页码:85 / 91
页数:7
相关论文
共 52 条
[51]  
Yakovlev AG, 1997, J NEUROSCI, V17, P7415
[52]   Apoptosis of chondrocytes in transgenic mice lacking collagen II [J].
Yang, CL ;
Li, SW ;
Helminen, HJ ;
Khillan, JS ;
Bao, YH ;
Prockop, DJ .
EXPERIMENTAL CELL RESEARCH, 1997, 235 (02) :370-373